1. Home
  2. TPC vs KNSA Comparison

TPC vs KNSA Comparison

Compare TPC & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tutor Perini Corporation

TPC

Tutor Perini Corporation

HOLD

Current Price

$71.74

Market Cap

4.1B

ML Signal

HOLD

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

HOLD

Current Price

$50.64

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TPC
KNSA
Founded
1894
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
General Bldg Contractors - Nonresidential Bldgs
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.5B
IPO Year
2003
2018

Fundamental Metrics

Financial Performance
Metric
TPC
KNSA
Price
$71.74
$50.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
7
Target Price
$86.00
$60.86
AVG Volume (30 Days)
413.2K
461.7K
Earning Date
05-06-2026
04-28-2026
Dividend Yield
0.28%
N/A
EPS Growth
148.24
225.00
EPS
0.48
0.27
Revenue
$5,543,039,000.00
$677,564,000.00
Revenue This Year
$15.37
$37.48
Revenue Next Year
$9.99
$17.87
P/E Ratio
$143.17
$182.48
Revenue Growth
28.11
60.09
52 Week Low
$41.16
$26.27
52 Week High
$100.00
$59.87

Technical Indicators

Market Signals
Indicator
TPC
KNSA
Relative Strength Index (RSI) 45.06 49.82
Support Level $66.91 $44.95
Resistance Level $76.62 $59.87
Average True Range (ATR) 3.06 1.93
MACD 0.01 -0.25
Stochastic Oscillator 60.33 51.56

Price Performance

Historical Comparison
TPC
KNSA

About TPC Tutor Perini Corporation

Tutor Perini Corp offers general contracting, construction management, and design-build services to private and public customers. The company constructs and repairs transportation infrastructure, water-treatment facilities, and a wide range of buildings. Tutor Perini has three operating segments: Civil, Building, and Specialty Contractors. A majority of its revenue is generated from the Civil segment, which specializes in public works construction and the replacement and reconstruction of infrastructure. Its civil contracting services include construction and rehabilitation of highways, bridges, tunnels, mass-transit systems, military and other government facilities, and water management and wastewater treatment facilities. Geographically it derives key revenue from the United States.

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.

Share on Social Networks: